Multiple sclerosis and Epstein-Barr virus. New developments and perspectives;Multiple sklerose und Epstein-Barr-virus. Neue entwicklungen und perspektiven

Nervenarzt

Volumn 79, Issue 4, 2008, Pages 399-407

  Ruprecht, K ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Association; Epidemiology; Epstein Barr virus; Mechanism; Multiple sclerosis

Indexed keywords

VIRUS ANTIBODY;

ANTIBODY TITER; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; HUMAN; INFECTIOUS MONONUCLEOSIS; MULTIPLE SCLEROSIS; REVIEW; RISK FACTOR; SEROPREVALENCE; VIRUS INFECTION;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CHILD; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HERPESVIRUS 4, HUMAN; HUMANS; INFECTIOUS MONONUCLEOSIS; MULTIPLE SCLEROSIS; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SLOW VIRUS DISEASES; VIRULENCE;

EID: 43349098448     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-007-2335-8     Document Type: Review

References (30)

1. Alotaibi S, Kennedy J, Tellier R et al. (2004) Epstein-Barr virus in pediatric multiple sclerosis. JAMA 291: 1875-1879
2. Ascherio A, Munger KL, Lennette ET et al. (2001) Epstein-Barr virus antibodies and risk of multiple sclerosis: A prospective study. JAMA 286: 3083-3088
3. Ascherio A, Munger KL (2007) Environmental risk factors for multiple sclerosis. Part I: The role of infection. Ann Neurol 61: 288-299
4. Christensen T (2006) The role of EBV in MS pathogenesis. Int MS J 13: 52-57
5. Dalgleish AG (1997) Viruses and multiple sclerosis. Acta Neurol Scand [Suppl] 169: 8-15
6. Delorenze GN, Munger KL, Lennette ET et al. (2006) Epstein-Barr virus and multiple sclerosis: Evidence of association from a prospective study with long-term follow-up. Arch Neurol 63: 839-844
7. Gale CR, Martyn CN (1995) Migrant studies in multiple sclerosis. Prog Neurobiol 47: 425-448
8. Gilden DH (2005) Infectious causes of multiple sclerosis. Lancet Neurol 4: 195-202
9. Goldacre MJ, Wotton CJ, Seagroatt V, Yeates D (2004) Multiple sclerosis after infectious mononucleosis: Record linkage study. J Epidemiol Community Health 58: 1032-1035
10. Gronen F, Ruprecht K, Weissbrich B et al. (2006) Frequency analysis of HLA-B7-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes in patients with multiple sclerosis and healthy controls. J Neuroimmunol 180: 185-192
11. Haahr S, Höllsberg P (2006) Multiple sclerosis is linked to Epstein-Barr virus infection. Rev Med Virol 16: 297-310
12. Haahr S, Sommerlund M, Moller-Larsen A et al. (1992) Is multiple sclerosis caused by a dual infection with retrovirus and Epstein-Barr virus? Neuroepidemiology 11: 299-303
13. Lang HLE, Jacobsen H, Ikemizu S et al. (2002) A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat Immunol 3: 940-943
14. Levin LI, Munger KL, Rubertone MV et al. (2005) Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA 293: 2496-2500
15. Munger KL, Levin LI, Hollis BW et al. (2006) Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296: 2832-2838
16. Pender MP (2003) Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases. Trends Immunol 24: 584-588
17. Pohl D, Krone B, Rostasy K et al. (2006) High seroprevalence of Epstein-Barr virus in children with multiple sclerosis. Neuology 67: 2063-2065
18. Rasmussen-Nielsen T, Rostgaard K, Munk-Nielsen N et al. (2007) Multiple sclerosis after infectious mononucleosis. Arch Neurol 64: 72-75
19. Rickinson AB, Kieff E (2001) Epstein-Barr virus. In: Knipe DM, Howley PM (eds) Virology. 4th edn. Lippincott Williams and Wilkins, New York, pp 2575-2627
20. Sauce D, Larsen M, Curnow SJ et al. (2006) EBV-associated mononucleosis leads to long-term deficit in T-cell responsiveness to IL-15. Blood 108: 11-18
21. Sumaya CV, Myers LW, Ellison GW (1980) Epstein-Barr virus antibodies in multiple sclerosis. Arch Neurol 37: 94-96
22. Sundstrom P, Juto P, Wadell G et al. (2004) An altered immune response to Epstein-Barr virus in multiple sclerosis: A prospective study. Neurology 62: 2277-2282
23. Sutkowski N, Conrad B, Thorley-Lawson DA, Huber BT (2001) Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen. Immunity 15: 579-589
24. Tenser RB (2003) Epstein-Barr virus and risk of multiple sclerosis. JAMA 290: 192-193
25. Thacker EL, Mirzaei F, Ascherio A (2006) Infectious mononucleosis and risk for multiple sclerosis: A meta-analysis. Ann Neurol 59: 499-503
26. Thorley-Lawson DA (2005) EBV persistence and latent infection in vivo. In: Robertson ES (ed) Epstein-Barr Virus. Caister Academic Press, Wymondham, pp 309-358
27. Sechel AC van, Bajramovic JJ, Stipdonk MJ van et al. (1999) EBV-induced expression and HLA-DR-restricted presentation by human B cells of alpha B-crystallin, a candidate autoantigen in multiple sclerosis. J Immunol 162: 129-135
28. Wandstrat A, Wakeland E (2001) The genetics of complex autoimmune diseases: Non-MHC susceptibility genes. Nat Immunol 2: 802-809
29. Warner HB, Carp RI (1981) Multiple sclerosis and Epstein-Barr virus. Lancet 2: 1290
30. Willer CJ, Dyment DA, Risch NJ et al. (2003) Twin concordance and sibling recurrence rates in multiple sclerosis. Proc Natl Acad Sci 100: 12877-12882